GILEAD 701 (Truvada 200 mg / 300 mg)

Generic Name: emtricitabine/tenofovir

Pill with imprint GILEAD 701 is Blue, Capsule-shape and has been identified as Truvada 200 mg / 300 mg. It is supplied by Gilead Sciences.

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GILEAD 701

Truvada

Generic Name:

emtricitabine/tenofovir

Imprint:

GILEAD 701

Strength:

200 mg / 300 mg

Color:

Blue

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Gilead Sciences

Inactive Ingredients:

croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
water
FD&C Blue No. 2
aluminum oxide
hypromelloses
titanium dioxide
triacetin
Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
61958-0701	Gilead Sciences, Inc.
54569-5588	A-S Medication Solutions, LLC (repackager)
54868-5141	Physicians Total Care Inc. (repackager)
35356-0070	Lake Erie Medical and Surgical Supply (repackager)
52959-0969	H.J. Harkins Company, Inc. (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer